PARK NICOLLET CANCER CENTER
| Site name: | Park Nicollet Cancer Center | Active Prostate Cancer Clinical Trials: | |
| Contact: | Patrick J. Flynn, MD | That match your search: | No search performed |
| Phone: | 612-863-8585 | ||
| Site email: | Not Provided |
5
Active Prostate Cancer Clinical Trials at Park Nicollet Cancer Center:
| TRIAL ID | TITLE | TRIAL PHASE |
|---|---|---|
| NCT00430183 | Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer | Phase 3 |
| NCT00309985 | CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer [CHAARTED] | Phase 3 |
| NCT00567580 | A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy | Phase 3 |
| NCT00079001 | A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone | Phase 3 |
| NCT01251861 | Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy | Phase 2 |